Your browser doesn't support javascript.
loading
Definitive surgical treatment of osteomalacia induced by skull base tumor and determination of the half-life of serum fibroblast growth factor 23.
Hana, Taijun; Tanaka, Shota; Nakatomi, Hirofumi; Shojima, Masaaki; Fukumoto, Seiji; Ikemura, Masako; Saito, Nobuhito.
  • Hana T; Department of Neurosurgery, Faculty of Medicine, The University of Tokyo Hospital, Tokyo, Japan.
  • Tanaka S; Department of Neurosurgery, Faculty of Medicine, The University of Tokyo Hospital, Tokyo, Japan.
  • Nakatomi H; Department of Neurosurgery, Faculty of Medicine, The University of Tokyo Hospital, Tokyo, Japan.
  • Shojima M; Department of Neurosurgery, Faculty of Medicine, The University of Tokyo Hospital, Tokyo, Japan.
  • Fukumoto S; Department of Endocrinology, Faculty of Medicine, The University of Tokyo Hospital, Tokyo, Japan.
  • Ikemura M; Department of Pathology, Faculty of Medicine, The University of Tokyo Hospital, Tokyo, Japan.
  • Saito N; Department of Neurosurgery, Faculty of Medicine, The University of Tokyo Hospital, Tokyo, Japan.
Endocr J ; 64(10): 1033-1039, 2017 Oct 28.
Article en En | MEDLINE | ID: mdl-28768937

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Osteomalacia / Neoplasias Complejas y Mixtas / Neoplasias de la Base del Cráneo / Factores de Crecimiento de Fibroblastos Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Adult / Female / Humans Idioma: En Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Osteomalacia / Neoplasias Complejas y Mixtas / Neoplasias de la Base del Cráneo / Factores de Crecimiento de Fibroblastos Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Adult / Female / Humans Idioma: En Año: 2017 Tipo del documento: Article